We are live on !
Find out more
Globeflex Capital Portfolio holdings
AUM
$783M
Turnover
28.73%
1-Year Est. Return
81.58%
This Fund
S&P 500
This Quarter Est. Return
+34.81%
1 Year Est. Return
+81.58%
3 Year Est. Return
+185.88%
5 Year Est. Return
+280.02%
10 Year Est. Return
+1,365.88%
AUM
$783M
AUM Growth
+$122M
(+18%)
Cap. Flow
-$22.1M
Cap. Flow % of AUM
Cap. Flow %
-2.82%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
456
New
69
Increased
67
Reduced
73
Closed
62
Avg Time Held
1.9
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ciena
CIEN
|
+$6.96M |
| 2 |
MYR Group
MYRG
|
+$4.57M |
| 3 |
Leonardo DRS
DRS
|
+$4.16M |
| 4 |
Semtech
SMTC
|
+$3.99M |
| 5 |
Everpure Inc
P
|
+$3.43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Catalyst Pharmaceutical
CPRX
|
+$11.2M |
| 2 |
Credicorp
BAP
|
+$9.17M |
| 3 |
Nextpower Inc. Common Stock
NXT
|
+$6.93M |
| 4 |
XP
XP
|
+$6.54M |
| 5 |
Sterling Infrastructure
STRL
|
+$5.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.62% |
| 2 | Industrials | 20.44% |
| 3 | Financials | 17.73% |
| 4 | Healthcare | 17.14% |
| 5 | Consumer Discretionary | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
326
Target
TGT
$75.4B
| $173K | 0.02% |
+1,322
| New | +$168K |
2026 Q2
0 quarters
|
|
327
RenaissanceRe
RNR
$14.1B
| $171K | 0.02% |
539
| – | – |
2026 Q1
1 quarter
|
|
328
Paylocity
PCTY
$9.28B
| $170K | 0.02% |
1,624
| – | – |
2022 Q3
15 quarters
|
|
329
L3Harris
LHX
$50.5B
| $162K | 0.02% |
557
| – | – |
2025 Q4
2 quarters
|
|
330
Strawberry Fields REIT
STRW
$175M
| $161K | 0.02% |
11,731
| – | – |
2026 Q1
1 quarter
|
|
331
Healthcare Realty
HR
$6.55B
| $161K | 0.02% |
7,988
| – | – |
2026 Q1
1 quarter
|
|
332
Reinsurance Group of America
RGA
$17.4B
| $161K | 0.02% |
+757
| New | +$158K |
2026 Q2
0 quarters
|
|
333
Cullen/Frost Bankers
CFR
$9.8B
| $159K | 0.02% |
1,032
| – | – |
2026 Q1
1 quarter
|
|
334
Bank7 Corp
BSVN
$633M
| $159K | 0.02% |
3,244
| – | – |
2024 Q1
9 quarters
|
|
335
MarketAxess Holdings
MKTX
$5.83B
| $156K | 0.02% |
1,371
| – | – |
2024 Q4
6 quarters
|
|
336
Byline Bancorp
BY
$1.73B
| $154K | 0.02% |
4,095
| – | – |
2023 Q3
11 quarters
|
|
337
Huntington Ingalls Industries
HII
$12B
| $152K | 0.02% |
544
| – | – |
2025 Q4
2 quarters
|
|
338
Sysco
SYY
$38.6B
| $152K | 0.02% |
1,817
| – | – |
2024 Q4
6 quarters
|
|
339
Ross Stores
ROST
$75.7B
| $151K | 0.02% |
711
| – | – |
2026 Q1
1 quarter
|
|
340
Magnera Corp
MAGN
$464M
| $147K | 0.02% |
+12,524
| New | +$137K |
2026 Q2
0 quarters
|
|
341
Pegasystems
PEGA
$5.09B
| $147K | 0.02% |
4,900
| – | – |
2025 Q2
4 quarters
|
|
342
Brink's
BCO
$4.72B
| $146K | 0.02% |
1,541
| – | – |
2025 Q3
3 quarters
|
|
343
Capital City Bank Group
CCBG
$879M
| $144K | 0.02% |
2,915
| – | – |
2025 Q3
3 quarters
|
|
344
Starling Oncology
STLN
$408M
| $142K | 0.02% |
+26,111
| New | +$110K |
2026 Q2
0 quarters
|
|
345
Visa
V
$788B
| $141K | 0.02% |
410
| – | – |
2023 Q2
12 quarters
|
|
346
MACOM Technology Solutions
MTSI
$17.6B
| $136K | 0.02% |
+357
| New | +$118K |
2026 Q2
0 quarters
|
|
347
TE Connectivity
TEL
$62.9B
| $136K | 0.02% |
673
| – | – |
2022 Q3
15 quarters
|
|
348
Tyson Foods
TSN
$21.1B
| $134K | 0.02% |
+2,338
| New | +$146K |
2026 Q2
0 quarters
|
|
349
eGain
EGAN
$156M
| $133K | 0.02% |
21,093
| – | – |
2022 Q2
16 quarters
|
|
350
Gentherm
THRM
$1.65B
| $133K | 0.02% |
+3,885
| New | +$125K |
2026 Q2
0 quarters
|
|
Similar funds
QCM
Globeflex Capital's Q2 2026 Portfolio in Review
As of Q2 2026, Globeflex Capital held 456 positions worth $783M, up 18% from $661M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Globeflex Capital's Q2 2026 filing shows 69 new, 67 increased, 73 reduced and 62 closed positions. Its largest new stake was Ciena: 13,648 shares worth $6.7M. The largest sale was Catalyst Pharmaceutical, an estimated $11.2M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 22% a quarter earlier, followed by Industrials and Financials.
- Globeflex Capital's largest Q2 2026 buy was Ciena: 13,648 shares worth $6.7M.
- Globeflex Capital added most to MYR Group in Q2 2026, an estimated $4.57M increase.
- Globeflex Capital's biggest Q2 2026 reduction was Rigel Pharmaceuticals, cutting an estimated $3.24M.
- Globeflex Capital fully exited Catalyst Pharmaceutical in Q2 2026, selling an estimated $11.2M.
- Globeflex Capital's ten largest holdings make up 18% of its $783M portfolio in Q2 2026.
- Globeflex Capital opened 69 new positions and closed 62 in Q2 2026.
- Globeflex Capital's portfolio value rose 18% quarter-over-quarter to $783M.
Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.